Beckman Coulter Life Sciences is taking actions in the best interests of our associates, customers, and business partners as we navigate the growing threats of the 2019 Novel Coronavirus disease (COVID-19). Learn more
ESCCA 2016 presentation provides an overview of flow cytometry immunophenotyping and the use of ClearLab IVD antibody cocktails in diagnosing hematologic malignancies. Includes summary of a feasible two-step approach with a screening tube and related diagnostic results.
Oops. The page you wanted could not be found, so we brought you to something similar. If you still can't find what you want, try searching our site instead.